Facebook
Twitter
LinkedIn
Forward
0231_ABSMC_Multi Cancer Early Detection_Live
Course Description:
Dhruva et al. (2023) state that "in recent years, blood tests that look for circulating tumor DNA and biomarkers (termed liquid biopsies) have been developed...these tests are being explored for diagnosis of suspected cancer, cancer surveillance after treatment, response to therapy, and chemotherapeutic selection. Most importantly, these blood tests are also being explored as multicancer early detection (MCED) tests for cancer screening in asymptomatic persons. Before US Food and Drug Administration (FDA) approval, insurer coverage, and clinical adoption of these technologies, rigorously conducted randomized clinical trials (RCTs) must be conducted demonstrating reductions in all-cause mortality to ensure that potential harms associated with these novel technologies do not exceed potential benefits." While multi-cancer early detection (MCED) tests have the potential to find more than one type of cancer from a single sample of blood, thus adding an innovative screening option, there is not yet sufficient evidence to know if MCED tests are useful. This presentation explores the current state of the science on MCEDs and invites discussion on how usefulness might be evaluated.
Target Audience
Physicians (MD or DO)
Learning Objectives
After completion of this session, learners will be able to:
1. Describe what MCED tests are and how they work.
2. Evaluate current evidence for the effectiveness and usefulness of MCED tests.
3. Demonstrate the ability to counsel patients regarding MCED test use and interpretation of results based on currently available evidence.
Assembly Bills 1195 & 241- Providing Culturally Appropriate Care which is Free of Implicit Biases:
- Markus, A., Li, Y., Wilder, M., Catalanotti, J., & McCarthy, M. (2023). The influence of social determinants on cancer screening in a Medicaid sample. AJPM; 65(1): 92-100. https://doi.org/10.1016/j.amepre.2023.02.005
- White, P. & Itzkowitz, S. (2020). Barriers driving racial disparities in colorectal cancer screening in African Americans. Current Gastroenterology Reports; 22(41). https://doi.org/10.1007/s11894-020-00776-0
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
Ronald Adler, MD
Ursula Boynton, MD
Brian Candell, MD
Masoud Chopan, D.O.
Golde Dudell, MD
Hussain Gilani, MD
Daniel Montes
Glen Petersen, MD
Ajay Upadhyay
Nerissa Moore
Jonathan Lee, MD, MAS
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.